HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy
Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.
Stay updated with breaking news from Transcriptome Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.
TUCSON, Ariz., June 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) today highlighted a peer reviewed journal article featuring the HTG Transcriptome Panel (HTP) less than one year after the breakthrough product’s commercial release.
TUCSON, Ariz., June 06, 2022 -- HTG Molecular Diagnostics, Inc. , a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today... | June 6, 2022
TUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...